Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
1 Inleiding in de radiotherapie hoofdstuk lezen eerste hoofdstuk lezen

2020 | OriginalPaper | Hoofdstuk

9 Brachytherapie

Auteurs : E. Kaljouw, MSc, M. A. Moerland, Ph.D., B. R. Pieters, M.D., PhD.

Gepubliceerd in: Techniek in de radiotherapie

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

Inhoud – 1 Inleiding – 2 Fysische en biologische aspecten van brachytherapie – 3 Klinische toepassingen – 4 Kwaliteitscontrole – Brachytherapie is een vorm van inwendige bestraling, waarbij radioactieve bronnen met applicatoren direct in of dicht tegen het tumorweefsel geplaatst worden. Kenmerkend zijn een hoge dosis in de tumor en een relatief lage dosis in omliggende organen door de steile dosisgradiënt. De radioactieve bronnen kunnen verschillende dosistempi hebben, hetgeen mede bepaalt of de bronnen permanent of tijdelijk in de patiënt geïmplanteerd worden. Andere kenmerken die bepalen of een bron geschikt is voor brachytherapie zijn de halveringstijd, het soort en de energie van de uitgezonden straling en de specifieke activiteit. Brachytherapie wordt onder andere toegepast bij gynaecologische en urologische tumoren en tumoren uitgaande van de tractus digestivus, mamma en huid. Voor reconstructie van de applicator en dosisplanning wordt US, CT of MRI gebruikt. Om de kwaliteit van de brachytherapiebehandeling te garanderen, worden de nauwkeurigheid van de dosisafgifte, de werking van de apparatuur, de applicatoren en het planningssysteem regelmatig getest.
vorige hoofdstuk 8 Techniek en toepassing van beeldgestuurde radiotherapie
volgende hoofdstuk 10 Kwaliteitsborging, kwaliteitscontroles en veiligheid
Literatuur
1.
Venselaar, J., & Baltas, D. (2014). Brachytherapy physics: Sources and dosimetry. The GEC ESTRO handbook of brachytherapy: Part I: The basics of brachytherapy. Brussel: ESTRO.
2.
Bhatnagar, A., Patel, R., Werschler, W. Ph, Ceilley, R. I., & Strimling, R. (2016). High-dose rate electronic brachytherapy: A nonsurgical treatment alternative for nonmelanoma skin cancer. Journal of Clinical Aesthetic Dermatology, 9(11), 16–22.PubMed
3.
Barati, B., Zabihzadeh, M., Birgani, M. J. T., Chegini, N., Ghahfarokhi, M. H., & Fatahiasl, J. (2017). Assessment of two hemispherical and hemispherical-conical miniature sources used in electronic brachytherapy using Monte Carlo simulation. Electron Physician, 9(2), 3845–3856.CrossRef
4.
Eaton, D. J. (2015). Electronic brachytherapy, current status and future directions. British Journal of Radiology, 88(1049), 20150002.CrossRef
5.
Liu, D., Poon, E., Bazalova, M., Reniers, B., Evans, M., Rusch, Th., et al. (2008). Spectroscopic characterization of a novel electronic brachytherapy system. Physics in Medicine & Biology, 53(1), 61–75.CrossRef
6.
Haie-Meder, C., Pötter, R., Limbergen, E. van, Briot, E., Brabandere, M. de, Dimopoulos, J., et al. (2005). Recommendations from gynaecological (GYN) GEC-ESTRO working group I: Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiotherapy and Oncology, 74, 235–245.CrossRef
7.
Pötter, R., Haie-Meder, C., Limbergen, E. van, Barillot, I., Brabandere, M. de, Dimopoulos, J., et al. (2006). Recomendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy – 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiotherapy and Oncology, 78, 67–77.CrossRef
8.
Stock, R. G., Stone, N. N., Cesaretti, J. A., & Resenstein, B. S. (2006). Biologicaly effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results. International Journal of Radiation Oncology Biology Physics, 64(2), 527–533.CrossRef
9.
Ash, D., Al-Qaisieh, B., Bottomley, D., Carey, B., & Joseph, J. (2006). The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer. Radiotherapy and Oncology, 79(2), 185–189.CrossRef
10.
Polo, A., Salembier, C., Venselaar, J., & Hoskin, P. (2010). Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. Radiotherapy and Oncology, 94, 12–23.CrossRef
11.
Hoskin, P., Rojas, A. M., Ostler, P., Hughes, R., Alonzi, R., Bryant, L., et al. (2016). Single dose versus two fractions high-dose rate afterloading brachytherapy for localised prostate cancer. Brachytherapy, 15, S50.CrossRef
12.
Hoskin, P. J., Colombo, A., Henry, A., Niehoff, P., Paulsen Hellebust, T., Siebert, F., et al. (2013). GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update. Radiotherapy and Oncology, 107, 325–332.CrossRef
13.
Morton, G., Chung, H. T., McGuffin, M., Helou, J., D’Alimonte, L., Ravi, A., et al. (2017). Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy. Radiotherapy and Oncology, 122, 87–92.CrossRef
14.
Prada, P. J., Cardenal, J., Blanco, A. G., Anchuelo, J., Ferri, M., Fernandez, G., et al. (2016). High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results. Radiotherapy and Oncology, 119, 411–416.CrossRef
15.
Zamboglou, N., Tselis, N., Baltas, D., Buhleier, T., Martin, T., Milickovic, N., et al. (2013). High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: Treatment evolution and mature results. International Journal of Radiation Oncology Biology Physics, 85, 672–678.CrossRef
16.
Yamada, Y., Kollmeier, M. A., Pei, X., Kan, C. C., Cohen, G. N., Donat, S. M., et al. (2014). A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy, 13, 111–116.CrossRef
17.
Vargas, C., Sartz, S., Vashi, A., Blasser, M., Kasraeian, A., Cesaretti, J., et al. (2014). Salvage brachytherapy for recurrent prostate cancer. Brachytherapy, 13, 53–58.CrossRef
18.
Gomez-Veiga, F., Marino, A., Alvarez, L., Rodriquez, I., Fernandez, C., Pertega, S., et al. (2012). Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy. BJU International, 10(9 Suppl 1), 17–21.
19.
Pieters, B. R., Steen-Banasik, E. van der, Smits, G. A., Brabandere, M. de, Bossi, A., & Limbergen, E. van (2016). GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma. Radiotherapy and Oncology, 122(3), 340–346.CrossRef
20.
Nap-van Klinken, A., Bus, S. J. E. A., Janssen, T. G., Gellekom, M. P. R. van, Smits, G., & Steen-Banasik, E. van der (2014). Interstitial brachytherapy for bladder cancer with the aid of laparoscopy. Journal of Contemporary Brachytherapy, 6, 313–317.CrossRef
21.
Steen-Banasik, E. M. van der, Smits, G. A. H. J., Oosterveld, B. J., Janssen, T., & Visser, A. G. (2016). The Curie–Da Vinci connection: 5-Years’ experience with laparoscopic (robot-assisted) implantation for high-dose-rate brachytherapy of solitary t2 bladder tumors. International Journal of Radiation Oncology Biology Physics, 95, 1439–1442.CrossRef
22.
Pieters, B. R., Steen-Banasik, E. van der, & Limbergen, E. van (2015). Urinary bladder cancer. The GEC ESTRO handbook of brachytherapy (2nd ed.). Brussel: ESTRO.
23.
Rovirosa, A., Anchuelo, J., Crispin, V., Gutiérrez, C., Herreros, A., Herruzo, I., et al. (2015). Recommendations of the Spanish brachytherapy group of SEOR for HDR endoluminal treatments. Part 1: Oesophagus. Clinical and Translational Oncology, 17(8), 581–589.
24.
Myint, A., Lee, Ch., & Gerard, J. (2014). Rectal cancer. The GEC ESTRO handbook of brachytherapy (2nd ed.) Brussel: ESTRO.
25.
Major, T., & Polgar, C., (2017). Treatment planning for multicatheter interstitial brachytherapy of breast cancer. From Paris system to anatomy-based inverse planning. Journal of Contemporary Brachytherapy, 9(1), 89–98.
26.
Strnad, V., Ott, O., Hildebrandt, G., Kauer-Dorner, D., Knauerhase, H., & Major, T. (2016). 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: A randomised, phase 3, non-inferiority trial. The Lancet, 387, 229–238.CrossRef
27.
Guinot, J., Pérez-Calatayud, J., & Limbergen, E. van (2017). Skin cancer. The GEC ESTRO handbook of brachytherapy (2nd ed.). Brussel: ESTRO.
28.
Elfrink, R., Kleffens, H. van, Kolkman-Deurloo, I., Rijnders, A., Schaeken, B., et al. (2002). Quality control in brachytherapy, current practice and minimum requirements. Report 13 of the Netherlands commission on radiation dosimetry. Radiotherapy and Oncology, 62(1), 95–102.
29.
Aalbers, A., Brabandere, M. de, Koedooder, C., Moerland, M. A., Rijnders, A., & Schaeken, B. (2012). Dosimetry and quality control of brachytherapy with low-energy photon sources ( 125I). Report 20 of the Netherlands Commission on Radiation Dosimetry. Delft: NCS.
30.
Nath, R., Anderson, L., Meli, J., Olch, A. J., Stitt, J. A., & Williamson, J. F. (1997). Code of practice for brachytherapy physics: Report of the AAPM radiation therapy committee task group no. 56. Medical Physics, 24(10), 1557–1598.
31.
Daskalov, G., Löffler, E., & Williamson, J. (1998). Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source. Medical Physics, 25(11), 2200–2208.CrossRef
32.
Rivard, M., Coursey, B., DeWerd, L., Hanson, W. F., Hug, M. S., & Ibbott, G. S. (2004). Update of AAPM task group no. 43 report: A revised AAPM protocol for brachytherapy dose calculations. Medical Physics, 31(3), 633–674.
33.
Beaulieu, L., Carlsson Tedgren A., Carrier, J. F., Davis, S. D., Mourtada, F., Rivard, M. J., et al. (2012). Report of the task group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: Current status and recommendations for clinical implementation. Medical Physics, 39(10), 6208–6236.CrossRef
Metagegevens
Titel
9 Brachytherapie
Auteurs
E. Kaljouw, MSc
M. A. Moerland, Ph.D.
B. R. Pieters, M.D., PhD.
Copyright
2020
Uitgeverij
Bohn Stafleu van Loghum
Boek
Techniek in de radiotherapie

Print ISBN: 978-90-368-2476-7

Elektronisch ISBN: 978-90-368-2477-4

Copyright: 2020

DOI
https://doi.org/10.1007/16013_2018_1